does glp-1 cause blood clots Do Medications Clots? Understanding the Risks and Mechanisms – PlexusDx April 2025 PEP Talk: Weight,

The majority of GLP-1 medications are only approved for adults 18 years and older

In April 2025, the FDA banned the sale of "counterfeit" semaglutide and tirzepatide from unauthorized sources

Abbreviations Alb: Albumin ANCOVA: Analysis of covariance APACHE II: Acute physiology and chronic health evaluation II Bil-D: Direct bilirubin Bill-T: Total bilirubin BMI: Body mass index BUN: Blood urea nitrogen CAT: Catalase CBC: Complete blood count Cl: Chloride Cr: Creatinine CRP: C-reactive protein DBP: Diastolic blood pressure ESR: Erythrocyte sedimentation rate GR: Glutathione reductase GSH: Glutathione GSH-Px: Glutathione-peroxidase ICU: Intensive care unit IL-6: Interleukin-6 iNOS: Induced nitric oxide synthase ITT: Intention-to-treat LC: L-carnitine MCH: Mean corpuscular volume MCHC: Mean corpuscular volume concentration MDA: Malondialdehyde NADPH-oxidase: Nicotinamide-adenine-dinucleotide phosphate-oxidase Nrf2: Nuclear-factor-erythroid-2-related-factor-2 NF-kB: Nuclear factor kappa B NO: Nitric oxide NUTRIC: Nutrition risk in the critically ill PAMPs: Pathogen-associated molecular patterns Plt: Platelet PO 2 : Blood pressure of oxygen PPAR: Peroxisome-proliferator activated-receptor PT: Prothrombin time PTT: Partial prothrombin time qSOFA: Quick SOFA RNS: Reactive nitrogen species ROS: Reactive oxygen species SBP: Systolic blood pressure SCCM: Society of critical care medicine SD: Standard deviation SOD: Superoxide dismutase SOFA: Sequential organ failure assessment TAC: Total antioxidant capacity TNF-: Tumor necrosis factor- WBC: White blood cell XO: Xanthine-oxidase References Huang M, Cai S, Su J

This suggests that the low starting level of S-palmitoylation of Go-Nt 7 at the PM makes it particularly sensitive to overexpression of zDHHC11, sufficient to relocalize significant quantities of Go-Nt 7 to this compartment without a measurable increase in [ 3 H]palmitate

But healthcare behaves more like a utilitysubject to policy swings and payer power

J., and DiMaio D